ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 563,70
-0,90%
Dow Jones
40 700,15
1,21%
DAX
18 480,87
-0,64%
Brent Oil
83,14
-1,42%
Bitcoin
63 224,51
-2,52%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
02/03/201523h29Dow Jones NewsMylan Posts Higher Profit and SalesNYSE:TEVATeva Pharmaceutical Industries Ltd
02/03/201515h50Dow Jones NewsCorrection to Story About Teva Selling Pennsylvania FacilityNYSE:TEVATeva Pharmaceutical Industries Ltd
02/03/201515h18Dow Jones NewsTeva Sells Pennsylvania Facility to G&W LaboratoriesNYSE:TEVATeva Pharmaceutical Industries Ltd
02/03/201514h29Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
02/03/201514h22Business WireTeva Announces Sale of Sellersville, PA FacilityNYSE:TEVATeva Pharmaceutical Industries Ltd
27/02/201514h30Business WireTeva Announces Early Results of Debt Tender Offer, Pricing, Election of Early Settlement & Increase in Maximum Amount & Prior...NYSE:TEVATeva Pharmaceutical Industries Ltd
26/02/201514h00Business WireTeva to Present at the Cowen & Company 35th Annual Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
25/02/201514h00Business WireTeva Announces FDA Acceptance for Review of NDA for its Investigational Twice-Daily Hydrocodone Bitartrate Extended-Release T...NYSE:TEVATeva Pharmaceutical Industries Ltd
24/02/201515h00Business WireTeva Announces Positive Results for TEV-48125 in Phase IIb Chronic Migraine Study Meeting Primary and Secondary EndpointsNYSE:TEVATeva Pharmaceutical Industries Ltd
23/02/201521h00Business WireThe Lancet Respiratory Medicine & AAAAI Publish Positive Data from Phase III Trials of Teva’s Reslizumab for the Treatment ...NYSE:TEVATeva Pharmaceutical Industries Ltd
20/02/201514h00Business WireTeva to Present New Respiratory Data at 2015 Annual Meeting of the American Academy of Allergy, Asthma and ImmunologyNYSE:TEVATeva Pharmaceutical Industries Ltd
18/02/201500h36Dow Jones NewsADR Shares End Higher; Chinese Oil Majors' Shares RiseNYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/201523h30Business WireLaw Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Teva Pharmaceutical Industries Ltd. StockholdersNYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/201514h33Dow Jones NewsTeva to Distribute Eagle Pharmaceutical's Cancer Drug in U.S.NYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/201514h30Business WireTeva Bolsters Injectable Portfolio with Launch of Generic Lovenox® and Generic Zyvox® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/201513h00Business WireTeva and Eagle Pharmaceuticals Announce Teva’s License to Commercialize Eagle’s Bendamustine Rapid Infusion ProductNYSE:TEVATeva Pharmaceutical Industries Ltd
13/02/201519h59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:TEVATeva Pharmaceutical Industries Ltd
12/02/201514h26Business WireTeva Announces $1 Billion Debt Tender OfferNYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/201508h51Business WireTeva Files 2014 Annual Report on Form 20-FNYSE:TEVATeva Pharmaceutical Industries Ltd
09/02/201522h29Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (f-3asr)NYSE:TEVATeva Pharmaceutical Industries Ltd
09/02/201522h10Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:TEVATeva Pharmaceutical Industries Ltd
06/02/201500h01Dow Jones NewsADR Shares End Higher; Tata Motors Shares FallNYSE:TEVATeva Pharmaceutical Industries Ltd.
05/02/201513h00Business WireTeva Reports Fourth Quarter and Full Year 2014 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
05/02/201512h30Business WireTeva Thanks Dr. Phillip Frost for Board ServiceNYSE:TEVATeva Pharmaceutical Industries Ltd
26/01/201521h23Business WireTeva Receives FDA Approval for First Generic Nexium® Delayed-Release Capsules in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
26/01/201514h10Dow Jones NewsFDA Rejects Antares' Application for Generic Migraine DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
21/01/201500h03Dow Jones NewsADR Shares End Mixed; SAP Shares FallNYSE:TEVATeva Pharmaceutical Industries Ltd.
20/01/201523h13Dow Jones NewsSupreme Court Sides With Teva in Patent Case on Copaxone -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
20/01/201518h59Dow Jones NewsSupreme Court Sides With Teva in Patent Case on Copaxone -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
20/01/201517h25Business WireTeva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE® 20 mg/mL Case & Remand...NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

LSE
JD.
Jd Sports Fashion
NASDAQ
VREX
Varex Imaging
BOV
MTSA4
METISA PN
LSE
BS9A
Ivz 2029 Usd A
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés